CAR T Cell Therapy in India: 8 Best Hospitals for Blood Cancers

CAR T cell therapy in India is available at 8 hospitals in this guide. The Indian made product NexCAR19 is expected to cost about USD 50,000, against about USD 400,000 for a CAR T infusion in the US.

CAR T is a personalised immunotherapy for blood cancers that have returned or stopped responding to chemotherapy or a transplant.

Reading this for a parent, partner or child with relapsed leukaemia or lymphoma? Start with the hospital table below. 

Then see what the cost of CAR T cell therapy in India includes and which cancers the Indian products cover. 

Each hospital names the unit that gives the treatment, so you know where your reports should go.

At My 1Health, we partner with some of the best hospitals in India for CAR T cell therapy to help international families reach CAR T cell therapy in India. 

We send your reports to the right hospital team, arrange a video consultation and a written estimate, and coordinate your visa letter, airport pickup and stay, free for the patient.

We take care of everything, so you can focus on getting better

Trusted by Millions Seeking World-Class Treatment

Instant visa letter

Flight bookings

Airport pickup

Accommodation

24/7 support

Find out what's included →

CAR T cell therapy cost in India compared with the US 

The product behind CAR T cell therapy in India costs about USD 50,000 to 60,000, against about USD 400,000 for a CAR T infusion in the US.

Your total depends on the hospital's plan, your length of stay and any intensive care. Each hospital sends a written estimate in USD after its team reviews your reports.

In rupees, NexCAR19 was quoted at INR 30 to 40 lakh at approval (GlobalData, 2023). These are the makers' published figures, not hospital quotes.

What should a CAR T estimate include?

Ask each hospital for the same items, so you can compare like with like:

• Evaluation and tests
• T cell collection (apheresis)
• Cell manufacturing
• Chemotherapy before the infusion
• Hospital stay and monitoring
• Care for side effects
• Doctors' fees and inpatient medicines

We add accommodation, meals, transfers and visa costs to build a full trip figure with our health cost calculator.

8 best hospitals in India offering CAR T cell therapy  

BMT means bone marrow transplant. We verify every surgeon's credentials and every facility's licence before we recommend a partner.

Here are the 8 best hospitals in India offering CAR T cell therapy

1. Apollo Hospital: CAR T cell therapy at Apollo Cancer Centres 

Apollo Cancer Centres give CAR T cell therapy in Chennai, Kolkata, Navi Mumbai and Hyderabad.

In February 2024 the group became the first private hospital group in India to complete a CAR T programme, starting with NexCAR19.

• Treats B cell lymphoma and B cell acute lymphoblastic leukaemia in patients aged 15 and over
• Navi Mumbai: Dr Punit Jain, consultant haematologist and programme coordinator, leads the team
• Kolkata is a short flight from Dhaka and Kathmandu, so many families from Bangladesh and Nepal start there

Planning around Kolkata, Chennai or Navi Mumbai? Ask which Apollo unit suits your case.

2. Medanta Hospital: CAR T and bone marrow transplant in Gurugram 

Medanta Hospital runs CAR T inside its haematology and bone marrow transplant (BMT) departments in Gurugram, Noida and Lucknow.

• Noida: Dr Esha Kaul directs a department that offers half matched (haploidentical), matched unrelated and family donor transplants alongside CAR T
• Lucknow: Dr Anshul Gupta’s team gave its first CAR T infusion in 2024 to a patient whose leukaemia had stopped responding to treatment, a first for eastern and central Uttar Pradesh
• Gurugram: the paediatric BMT team lists CAR T for B cell leukaemia and some B cell lymphomas

No fully matched donor? Compare CAR T and a half matched transplant at Medanta.

3. Max Healthcare: CAR T cell therapy at Patparganj, Delhi 

Max Healthcare launched CAR T with ImmunoACT, the maker of NexCAR19, in December 2023. It announced the treatment at Max Super Speciality Hospital, Patparganj in April 2024.

• CAR T unit: Patparganj, Delhi
• The Max bone marrow transplant team treats patients across Saket, Vaishali, Patparganj and Shalimar Bagh, so transplant support sits in the same group
• Delhi is a short flight from Kathmandu and Dhaka

Travelling from Nepal or Bangladesh? Ask Max about Patparganj and your dates.

4. Fortis Hospitals: CAR T at Fortis Memorial Research Institute 

Fortis Hospitals give CAR T at Fortis Memorial Research Institute in Gurugram through the Fortis Institute of Blood Disorders, which opened in January 2024 and brought NexCAR19 to the Fortis transplant network.

• Dr Rahul Bhargava leads haematology, BMT and CAR T as principal director
• The Fortis network had completed more than 2,500 bone marrow transplants by January 2024
• June 2026: a new Centre of Excellence for Myeloma and Lymphoma opened in Gurugram

Want a plan from the Fortis blood disorders team? Send your reports for review.

5. HCG Hospitals: CAR T cell therapy at HCG Cancer Hospital  

HCG Hospitals give CAR T at HCG Cancer Hospital in Bengaluru, from a bone marrow transplant facility built for infection control and close monitoring.

• Haematologists, medical oncologists, transplant specialists, intensivists and pathologists review each patient together
• The programme follows nationally approved treatment protocols
• Patients are selected case by case after evaluation

Comparing Bengaluru with other cities? Request a written quote from HCG.

6. Kokilaben Dhirubhai Ambani Hospital: CAR T in Mumbai  

Kokilaben Dhirubhai Ambani Hospital in Mumbai was among the first in India to offer NexCAR19, from January 2024.

• Your own T cells are collected, modified in a laboratory and returned to you
• The BMT unit uses HEPA filtered air to protect patients from infection
• The team performs donor (allogeneic), own cell (autologous), peripheral stem cell and cord blood transplants, so CAR T and transplant planning happen together

Wondering whether NexCAR19 fits your diagnosis? Ask Kokilaben about your case.

7. Gleneagles Hospital: CAR T cell therapy in Chennai 

Gleneagles Hospital gives CAR T at its Perumbakkam hospital in Chennai, through haemato oncology and bone marrow transplant teams. For CAR T, ask for the Chennai unit.

• The process runs from patient selection to T cell collection, infusion and aftercare
• In 2026 the team treated a rare lymphoma of the central nervous system with CAR T
• Gleneagles Hospitals is part of IHH Healthcare

Need the Chennai unit confirmed? Confirm your CAR T plan at Gleneagles.

8. MGM Healthcare: CAR T cell therapy at MGM Cancer Institute 

MGM Healthcare gives CAR T at MGM Cancer Institute and MGM Healthcare Malar, Adyar in Chennai.

• In early 2026 the programme treated two elderly patients with aggressive cancers after conventional treatment had stopped working
• Protocols are designed for international patients seeking affordable cancer care, as well as Indian patients

See if MGM Healthcare suits your case and what a written estimate would cover.

Which cancers do NexCAR19 and Qartemi CAR T treat in India? 

India has 2 approved CAR T products. NexCAR19 (approved October 2023) covers B cell lymphoma and B cell acute lymphoblastic leukaemia (B ALL) from age 15.

Qartemi (approved January 2025) covers adult B cell lymphoma.

Both target CD19, a protein on B cells, and both are made from your own T cells.

Relapsed means the cancer returned. Refractory means it stopped responding to treatment.

CAR T is considered after chemotherapy, targeted therapy or a transplant has not controlled the disease.

• NexCAR19:26 of 38 lymphoma patients and 10 of 15 leukaemia patients responded, and none of the 53 evaluable patients had neurological side effects. A Lancet Haematology report gives 73% overall response in 51 patients.
• Qartemi: 83.3% overall response at 90 days in its phase 2 trial in adults with relapsed or refractory B cell lymphoma (AABB, January 2025).

Multiple myeloma needs a different target, BCMA, and India's approved products target CD19.

The hospital team reviews each myeloma case individually. BCMA CAR T is available through our partner hospitals in China: see our guide to CAR T hospitals in China.

Children under 15: a NexCAR19 trial in B cell leukaemia was under way at Tata Memorial in early 2024. Ask the hospital team about access.

CAR T and bone marrow transplant are often planned side by side. See our guide to bone marrow transplant hospitals in India.

Ask whether your diagnosis fits an Indian CAR T product · Ask about myeloma options in India and China

Why do international patients choose India for CAR T therapy? 

International patients choose CAR T cell therapy in India for three reasons: price, local manufacturing and choice of city.

• Price: the product costs about USD 50,000 to 60,000, against about USD 400,000 in the US.
• Indian made products: NexCAR19 and Qartemi are made in India, so your cells are engineered in the country where you are treated.
• Choice of city: eight hospitals across Delhi NCR, Mumbai, Chennai, Kolkata, Hyderabad and Bengaluru let you pick the city that suits your flights and budget.

What is the step by step process of CAR T cell therapy? 

CAR T cell therapy in India takes seven steps, and international patients usually plan for three to six weeks in the country.

1. Evaluation. A haematologist reviews your diagnosis, earlier treatment and organ function. Blood tests and scans confirm whether CAR T suits you.
2. T cell collection. A machine separates T cells from your blood (apheresis). It takes a few hours and needs no surgery.
3. Cell engineering. A laboratory modifies your T cells to recognise CD19 on cancer cells. This takes a few weeks.
4. Chemotherapy. A short course makes room for the new cells.
5. Infusion. The cells return through a drip, often in under an hour.
6. Monitoring. The team watches for fever, low blood pressure and neurological symptoms for one to two weeks and treats them promptly. In NexCAR19 trials, only 5% of patients had a severe cytokine release reaction (an overactive immune response).
7. Recovery. Regular blood tests and scans track your response, and your reports go to your doctor at home.

A family member usually travels with the patient, and we arrange accommodation near the hospital for both. For a week by week view of a long stay, see our bone marrow transplant abroad timeline.

How can My 1Health help you access CAR T in India for free?

We help international patients access CAR T cell therapy at no cost to them. You pay the hospital the same price you would pay going directly.

1. Share your diagnosis, scan reports and budget through the link below.
2. We send them to the CAR T specialist team at the hospital that fits your diagnosis.
3. The hospital's specialists review your reports and send a treatment plan and written cost estimate.
4. We coordinate the video consultation, appointments, visa documents, travel and stay.
5. One named patient support specialist stays with you before travel, during treatment and after you return home.

We take care of everything, so you can focus on getting better

Trusted by Millions Seeking World-Class Treatment

Instant visa letter

Flight bookings

Airport pickup

Accommodation

24/7 support

Find out what's included →

• Hospital matching: by cancer type, earlier treatment and budget
• Video consultation: with the hospital specialist before you travel
• Visa, pickup and stay: with interpreter support arranged through the hospital
• Records and follow up: your reports go to your doctor at home

Share your reports via this link